BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 22, 2008
View Archived Issues
First-in-human studies of HQK-1001 reported
Read More
Darinaparsin demonstrates activity, tolerability in advanced lymphomas
Read More
Preclinical anticancer activity of SAR-650984 presented
Read More
Merrimack reports preclinical efficacy for novel MM-111 antibody in experimental cancer models
Read More
MMV and GlaxoSmithKline to develop radical cure for Plasmodium vivax malaria
Read More
Addex initiates phase IIb ADX-10059 trial for GERD
Read More
A 3-day azithromycin/chloroquine therapy safe and effective in malaria patients
Read More
GSK extends tender offer to acquire Genelabs
Read More
Kamada completes enrollment in its phase II trial of inhaled AAT for bronchiectasis
Read More
Hawaii Biotech completes dosing in phase I trial of West Nile virus vaccine
Read More
Tibotec initiates recruitment in phase III trials of NNRTI drug TMC-278 for HIV
Read More
Pluristem files IMPD with German authority to initiate clinical trial of PLX-PAD in CLI
Read More
KeyNeurotek completes patient recruitment in phase IIa study of KN38-7271 in TBI
Read More
Cell Therapeutics and Spectrum form joint venture to market Zevalin in the U.S.
Read More
Amgen to meet with FDA to discuss clinical utility of KRAS oncology biomarker in mCRC
Read More
Theratechnologies and EMD Serono sign licensing agreement for tesamorelin
Read More
Bionomics successfully completes safety studies in animals of antianxiety drug BNC-210
Read More
BioXell completes patient enrollment in phase IIb clinical trial of elocalcitol in OAB
Read More
Generex and Pevion signed agreement to develop immunotherapeutic vaccines
Read More
Orphan Europe and CMIC sign Japanese license agreement for Normosang for hepatic porphyria
Read More
Neurobiological Technologies terminates further enrollment in clinical trials of Viprinex
Read More
Medivation completes enrollment in phase I/II trial of MDV-3100 in prostate cancer
Read More
Abbott exercises option to purchase remaining equity ownership in Ibis Biosciences
Read More
Novel agents for hematological diseases described in recent patents
Read More
Takeda and Asubio patents disclose new treatment options for cardiovascular disorders
Read More
